Evidence map›Paper›PMID 34626406›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Imaging Glycosaminoglycan Modification Patterns In Vivo.

Hannes E Bülow

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Hannes E BülowDepartment of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA. hannes.buelow@einsteinmed.org.
Albert Einstein College of Medicine · US

Funding

A Fluorescence-Based High-Throughput Platform for Glycotyping the Hematopoietic Cell LineageU01CA241981 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BUELOW, HANNES ERICH, STEIDL, ULRICH · 2019 to 2021
$1.3M
6 · The paper itself

Abstract

Glycosaminoglycans (GAGs) such as heparan sulfates (HS) or chondroitin sulfates (CS) are long unbranched polymers of a disaccharide comprised of hexuronic acid and hexosamine. Attached to a protein backbone via a characteristic tetrasaccharide, the GAG chains are non-uniformly modified by sulfations, epimerizations, and deacetylations. The resultant glycan chains contain highly modified domains, separated by sections of sparse or no modifications. These GAG domains are central to the role of glycans in binding to proteins and mediating protein-protein interactions. Since HS and CS domains are not genetically encoded, they cannot be visualized and studied with conventional methods in vivo. We describe a transgenic approach using single chain variable fragment (scFv) antibodies that bind HS or CS. By transgenically expressing fluorescently tagged scFv antibodies, we can directly visualize both HS and CS domains in live Caenorhabditis elegans revealing unprecedented cellular specificity and evolutionary conservation (Attreed et al., Nat Methods 9(5): 477-479, 2012; Attreed et al., Glycobiology 26(8): 862-870, 2016) (unpublished). The approach allows concomitant co-labeling of multiple GAG domains, the study of GAG dynamics, and could lend itself to a genetic analysis of GAG domain biosynthesis or function.

Indexed as

AnimalsAnimals, Genetically ModifiedCaenorhabditis elegansChondroitin SulfatesDisaccharidesGlycosaminoglycansHeparan SulfateSingle-Chain AntibodiesChondroitin SulfatesDisaccharidesGlycosaminoglycansHeparan SulfateSingle-Chain AntibodiesCaenorhabditisChondroitin sulfateDermatan sulfateGlycosaminoglycansHeparan sulfateLive imagingNon-genetically encoded moleculesSingle chain variable fragment (scFv) antibody

Identifiers

PMID34626406
OpenAlexW3204359896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.